Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Risk and Prevention Study of n-3 PUFA
NCT00317707Phase 3Completed
- Sponsor
- Mario Negri Institute for Pharmacological Research
- Start
- Feb 2004
- Primary completion
- Oct 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of omega-3-acid triglycerides in cardiovascular disease (CVD), sponsored by Mario Negri Institute for Pharmacological Research. Started Feb 2004; status: completed.
02
Drugs
omega-3-acid triglycerides
03
Conditions
cardiovascular disease (CVD)
Beyond the preview
Go deeper on NCT00317707.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00317707.